IPO Profile: Zynerba Pharmaceuticals Inc

The pharmaceutical company raised $42 million in its August IPO

1 September 2015•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.